Limited coverage criteria – tizanidine

Last updated on March 24, 2025

 

Return to Special Authority drug list  

Generic name

tizanidine         

Strength & form

4 mg tablet

Special Authority criteria

Approval period

Diagnosis of spasticity

PLUS

Documented evidence of treatment failure on or intolerance to diazepam or baclofen

Indefinite

Practitioner exemptions

  • None

Special notes

  • None

Special Authority request form(s)